118 related articles for article (PubMed ID: 38932350)
1. Protective Efficacy of the Epitope-Conjugated Antigen N-Tc52/TSkb20 in Mitigating
Vázquez ME; Zabala BA; Mesías AC; Biscari L; Kaufman CD; Alloatti A; Siano F; Picariello G; Corbalán NS; Lenis BA; Toscano MA; Parodi CM; Brandán CMP; Acuña L
Vaccines (Basel); 2024 Jun; 12(6):. PubMed ID: 38932350
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells.
Rosenberg CS; Zhang W; Bustamante JM; Tarleton RL
Infect Immun; 2016 Sep; 84(9):2627-38. PubMed ID: 27354447
[TBL] [Abstract][Full Text] [Related]
3. Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity.
Eickhoff CS; Zhang X; Vasconcelos JR; Motz RG; Sullivan NL; O'Shea K; Pozzi N; Gohara DW; Blase JR; Di Cera E; Hoft DF
PLoS Pathog; 2016 Sep; 12(9):e1005896. PubMed ID: 27642757
[TBL] [Abstract][Full Text] [Related]
4. Epitopes in the Glycosylphosphatidylinositol Attachment Signal Peptide of Trypanosoma cruzi Mucin Proteins Generate Robust but Delayed and Nonprotective CD8+ T Cell Responses.
Bunkofske ME; Perumal N; White B; Strauch EM; Tarleton R
J Immunol; 2023 Feb; 210(4):420-430. PubMed ID: 36603035
[TBL] [Abstract][Full Text] [Related]
5. Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi.
Matos MN; Cazorla SI; Schulze K; Ebensen T; Guzmán CA; Malchiodi EL
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005300. PubMed ID: 28234897
[TBL] [Abstract][Full Text] [Related]
6. The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection.
Ouaissi A; Guilvard E; Delneste Y; Caron G; Magistrelli G; Herbault N; Thieblemont N; Jeannin P
J Immunol; 2002 Jun; 168(12):6366-74. PubMed ID: 12055254
[TBL] [Abstract][Full Text] [Related]
7. CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance.
Rosenberg CS; Martin DL; Tarleton RL
J Immunol; 2010 Jul; 185(1):560-8. PubMed ID: 20530265
[TBL] [Abstract][Full Text] [Related]
8. Immunization With Lipopolysaccharide-Activated Dendritic Cells Generates a Specific CD8
Biscari L; Kaufman CD; Farré C; Huhn V; Pacini MF; Balbi CB; Gómez KA; Pérez AR; Alloatti A
Front Cell Infect Microbiol; 2022; 12():897133. PubMed ID: 35903201
[TBL] [Abstract][Full Text] [Related]
9. Targeting Myeloid-Derived Suppressor Cells to Enhance a Trans-Sialidase-Based Vaccine Against
Gamba JC; Roldán C; Prochetto E; Lupi G; Bontempi I; Poncini CV; Vermeulen M; Pérez AR; Marcipar I; Cabrera G
Front Cell Infect Microbiol; 2021; 11():671104. PubMed ID: 34295832
[No Abstract] [Full Text] [Related]
10. Generation of Trypanosoma cruzi-specific CD8+ T-cell immunity is unaffected by the absence of type I interferon signaling.
Martin DL; Murali-Krishna K; Tarleton RL
Infect Immun; 2010 Jul; 78(7):3154-9. PubMed ID: 20457790
[TBL] [Abstract][Full Text] [Related]
11. A novel multi-epitope recombinant protein elicits an antigen-specific CD8+ T cells response in Trypanosoma cruzi-infected mice.
González-López C; Chen WH; Alfaro-Chacón A; Villanueva-Lizama LE; Rosado-Vallado M; Ramirez-Sierra MJ; Teh-Poot CF; Pollet J; Asojo O; Jones KM; Hotez PJ; Elena Bottazzi M; Cruz-Chan JV
Vaccine; 2022 Oct; 40(45):6445-6449. PubMed ID: 36184402
[TBL] [Abstract][Full Text] [Related]
12. Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against
Antonoglou MB; Sánchez Alberti A; Redolfi DM; Bivona AE; Fernández Lynch MJ; Noli Truant S; Sarratea MB; Iannantuono López LV; Malchiodi EL; Fernández MM
Front Immunol; 2020; 11():1279. PubMed ID: 32695105
[TBL] [Abstract][Full Text] [Related]
13. Testing the efficacy of a multi-component DNA-prime/DNA-boost vaccine against Trypanosoma cruzi infection in dogs.
Aparicio-Burgos JE; Ochoa-García L; Zepeda-Escobar JA; Gupta S; Dhiman M; Martínez JS; de Oca-Jiménez RM; Val Arreola M; Barbabosa-Pliego A; Vázquez-Chagoyán JC; Garg NJ
PLoS Negl Trop Dis; 2011; 5(5):e1050. PubMed ID: 21625470
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.
Gupta S; Garg NJ
PLoS Negl Trop Dis; 2010 Aug; 4(8):e797. PubMed ID: 20706586
[TBL] [Abstract][Full Text] [Related]
15. Peptide-based analysis of the amino acid sequence important to the immunoregulatory function of Trypanosoma cruzi Tc52 virulence factor.
Borges M; Da Silva AC; Sereno D; Ouaissi A
Immunology; 2003 May; 109(1):147-55. PubMed ID: 12709028
[TBL] [Abstract][Full Text] [Related]
16. Vaccination With Recombinant Filamentous
Gomes-Neto JF; Sartorius R; Canto FB; Almeida TS; Dias AA; Barbosa CD; Melo GA; Oliveira AC; Aguiar PN; Machado CR; de Matos Guedes HL; Santiago MF; Nóbrega A; De Berardinis P; Bellio M
Front Immunol; 2018; 9():1173. PubMed ID: 29896197
[TBL] [Abstract][Full Text] [Related]
17. A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi.
Gupta S; Garg NJ
PLoS Pathog; 2015 May; 11(5):e1004828. PubMed ID: 25951312
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
[TBL] [Abstract][Full Text] [Related]
19. Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection.
Farrow AL; Rachakonda G; Gu L; Krendelchtchikova V; Nde PN; Pratap S; Lima MF; Villalta F; Matthews QL
PLoS Negl Trop Dis; 2014 Aug; 8(8):e3089. PubMed ID: 25144771
[TBL] [Abstract][Full Text] [Related]
20. Trypanosoma cruzi carrying a targeted deletion of a Tc52 protein-encoding allele elicits attenuated Chagas' disease in mice.
Garzón E; Borges MC; Cordeiro-da-Silva A; Nacife V; Meirelles Mde N; Guilvard E; Bosseno MF; Guevara AG; Brenière SF; Ouaissi A
Immunol Lett; 2003 Oct; 89(1):67-80. PubMed ID: 12946866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
